SCHEDULE: Summit Partners Discloses Stake in LifeStance Health

Summit Partners, through various affiliated entities, has updated its beneficial ownership filing for LifeStance Health Group, Inc., reporting a combined 4.37% stake.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of LifeStance Health Group, Inc. common stock.
• The reporting persons are various entities affiliated with Summit Partners, L.P.
• Collectively, the reporting persons hold a total of 16,623,824 shares of common stock.
• This represents approximately 4.37% of the outstanding common stock.
• The filing details the ownership breakdown across several Summit Partners entities, including Summit Partners, L.P., Summit Partners Growth Equity Fund IX-A, L.P., Summit Partners Growth Equity Fund IX-B, L.P., Summit Investors GE IX/VC IV (UK), L.P., Summit Partners Entrepreneur Advisors Fund II, L.P., and Summit Investors GE IX/VC IV, LLC.
• The shares are held with shared voting and dispositive power across these entities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine Schedule 13G filing disclosing beneficial ownership changes rather than new strategic or financial performance information.

Positives

• The filing clearly outlines the beneficial ownership of a significant investment firm, Summit Partners, in LifeStance Health Group, Inc.
• The reporting is transparent and follows regulatory requirements for disclosing significant stakes.

Negatives

• The filing does not provide any new financial performance data or strategic updates for LifeStance Health Group, Inc., limiting its immediate insight into the company's operational health.

Risks

• The filing does not explicitly mention any new risks or challenges for LifeStance Health Group, Inc.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding LifeStance Health Group, Inc.'s future performance.

Management Comments

• The filing includes a certification that the information set forth is true, complete, and correct.
• It is stated that the Reporting Persons disclaim beneficial ownership beyond their direct holdings, and the statement shall not be construed as an admission of beneficial ownership for Section 13(d) or 13(g) purposes by the investment committee members.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors like Summit Partners to report their holdings in publicly traded companies. This update reflects ongoing investment activity and portfolio management within the healthcare services sector.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding the ownership structure and the significant stake held by Summit Partners, which may influence market perception and trading activity.

Next Steps

• The Reporting Persons will continue to monitor their investment in LifeStance Health Group, Inc. and may adjust their holdings based on market conditions and strategic assessments.

Key Dates

Keywords

LifeStance Health, Summit Partners, Beneficial Ownership, Schedule 13G, Equity Fund, Investment Management